RSCM
OKUR

Rock Springs Capital Management’s OnKure Therapeutics OKUR Stock Holding History

Rock Springs Capital Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-75,173
Closed -$1.25M – 121
2024
Q1 		$1.25M Hold
75,173
– – 0.03% 111
2023
Q4 		$1.2M Sell
75,173
-39,146
-34% -$2.44M 0.03% 99
2023
Q3 		$8.71M Hold
114,319
– – 0.23% 76
2023
Q2 		$7.5M Hold
114,319
– – 0.18% 82
2023
Q1 		$6.84M Hold
114,319
– – 0.16% 83
2022
Q4 		$2.66M Hold
114,319
– – 0.06% 101
2022
Q3 		$3.83M Hold
114,319
– – 0.1% 101
2022
Q2 		$3.03M Hold
114,319
– – 0.09% 106
2022
Q1 		$3.36M Hold
114,319
– – 0.08% 114
2021
Q4 		$9.77M Hold
114,319
– – 0.23% 92
2021
Q3 		$8.52M Buy
114,319
+1,417
+1% +$120K 0.18% 113
2021
Q2 		$10.5M Buy
+112,902
New +$12.6M 0.21% 110

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Rock Springs Capital Management's OKUR Position: Q2 2024 in Review

Rock Springs Capital Management sold out of OnKure Therapeutics (OKUR) in Q2 2024, closing a stake of 75,173 shares — an estimated $1.25M sold.

Rock Springs Capital Management first reported a position in OKUR in Q2 2021 and held it in 12 quarters. The position peaked at $10.5M in Q2 2021. 66 funds tracked by Wall St. Rank hold OKUR as of Q2 2024.

  • Rock Springs Capital Management reported no remaining OnKure Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Rock Springs Capital Management sold 75,173 OnKure Therapeutics shares in Q2 2024, an estimated $1.25M.
  • Rock Springs Capital Management first reported a position in OnKure Therapeutics in Q2 2021 and held it in 12 quarters.
  • Rock Springs Capital Management's OnKure Therapeutics position peaked at $10.5M in Q2 2021.
  • 66 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2024.

Based on Rock Springs Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.